Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology-Reference-Cited by-同舟云学术

Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

Published:2014-03-22 Issue:4 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Uyeturk Ummugul,Oksuzoglu Berna,Akman Tulay,Turker Ibrahim,Sener Nur,Tastekin Didem,Bal Oznur,Berk Veli,Arslan Ulku Yalcintas,Urakci Zuhat,Bilir Cemil,Yilmaz Ugur,Yazilitas Dogan,Ulas Arife,Sonmez Ozlem Uysal,Budakoglu Burcin,Cihan Sener,Uysal Mukremin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0929-0.pdf

Reference41 articles.

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. doi: 10.3322/caac.20073 .

2. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology 2012;23 Suppl 7:vii11–9. doi: 10.1093/annonc/mds232 .

3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (Oxford, England: 1990) 2013;49(6):1374–403. doi: 10.1016/j.ejca.2012.12.027 .

4. Higgins MJ, Wolff AC. Therapeutic options in the management of metastatic breast cancer. Oncology (Williston Park, NY) 2008;22(6):614–23; discussion 23, 27–9.

5. Burstein HJ, Schwartz RS. Molecular origins of cancer. N Engl J Med. 2008;358(5):527. doi: 10.1056/NEJMe0800065 .

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty-five Years Overall Survival Prognostic Value of the Lymph Node Ratio inDe NovoMetastatic Breast Cancer;Anticancer Research;2024-04-27

2. Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review;Cancer Management and Research;2021-08

3. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19;International Journal of Medical Sciences;2020

4. Can maintenance trastuzumab be stopped in patients with HER2-positive metastatic breast cancer?;Case Reports;2015-06-03

5. Is there a role for locoregional surgery in stage IV breast cancer?;The Breast;2015-02